ArsenalBio

Description

Develops in vivo T cell therapies and reprogrammed CAR T approaches for chronic diseases, including cancer and autoimmunity, with focus on solid tumor challenges.

Related

• Iovance Biotherapeutics ($IOVA)Develops and manufactures tumor infiltrating lymphocyte therapies that use a patient’s immune cells, serving people with cancer and…
• Umoja BiopharmaDevelops in vivo CAR T cell therapies and lentiviral manufacturing to support on-demand treatment, aiming to reduce ex vivo manufacturing…
• Kyverna Therapeutics ($KYTX)Develops CAR T-cell therapies for autoimmune diseases, with clinical trials addressing conditions including stiff person syndrome and…
• Mammoth BiosciencesDevelops in vivo gene-editing therapeutics, engineers CRISPR-Cas systems and editing strategies, and provides CRISPR-based detection…
• Xaira TherapeuticsBuilds an AI-powered drug discovery and development platform to decode disease, design therapies, and support end-to-end medicine creation…
• ONK TherapeuticsONK Therapeutics develops ready-made natural killer cell therapies.
• Caribou Biosciences ($CRBU)Develops genome-edited allogeneic CAR-T cell therapies using CRISPR and chRDNA technology for patients with hematologic malignancies and…
• Altos LabsDevelops medicines based on cell rejuvenation, using computation, machine learning, and internal and external biological data to study cell…
• BMS Cell Therapy Washington ($BMY)Develops, manufactures, and commercializes cancer immunology and cell therapies for people with difficult-to-treat cancers and other…
• OriginBuilds maps of cancer biology in real tumors, capturing spatial gene expression and images to train clinical models and predict drug…
• Kyverna Therapeutics (San Diego)Develops cell therapies for autoimmune disease patients, including an autologous CD19-targeting CAR T candidate being studied in ongoing…
• March BiosciencesDevelops clinical-stage CAR-T cell therapies, including MB-105, aimed at difficult hematological cancers, with a focus on relapsed or…